Life Sciences & Biotechnology, COVID-19 Technology, Pharmaceutical Sciences, Startup Technologies
Title: | Standardised therapeutic dosage of plasma for treatment of COVID-19 |
Area: | Life Sciences & Biotechnology, COVID-19 Technology, Pharmaceutical Sciences, Startup Technologies |
Sub Area: | Covid treatment |
Focus Area: | Medical equipment |
Developing Agency: | Chimera Translational Research Fraternity, New Delhi |
Technology Readiness Index: | Technology developed |
Email: | info.ctrf@translational.in |
| Website Link : | http://translational.in/ |
Brief Description
Description : | A technology for delivering a standardised therapeutic dosage of plasma for treatment of COVID-19 patients so that just the right amount of dose is administered to the patient. The Lyophilised - COVID Antibody Rich Product (L-CARP) have developed a safe therapy and avoids transmission of infections by a strategic donor with the help of a screening process. They have developed a bank of L-CARP, to avoid the delay and hassle of finding, screening and withdrawing the plasma at the last minute. |
Related Technologies